Skip to main content

Table 1 The outstanding disease-free prognostic genes for colon cancer

From: Independent prognostic genes and mechanism investigation for colon cancer

Gene FC P GSE17536 GSE39582
Log-rank P HR 95% CI Log-rank P HR 95% CI
SFTA2 63.45 1.6E−91 8.87E−03 0.488 0.49 (0.28–0.84) 2.29E−02 0.708 0.71 (0.53–0.95)
LEMD1 32.47 4.3E−98 1.32E−02 0.506 0.51 (0.29–0.88) 1.47E−02 0.692 0.69 (0.51–0.93)
COMP 14.33 4.3E−82 3.70E−03 0.444 0.44 (0.25–0.78) 1.48E−02 0.691 0.69 (0.51–0.93)
KIF26B 6.86 2.4E−64 5.85E−03 0.466 0.47 (0.27–0.81) 1.09E−02 0.679 0.68 (0.5–0.92)
KLK10 6.06 1.1E−99 5.28E−03 0.462 0.46 (0.26–0.81) 7.06E−03 0.666 0.67 (0.49–0.9)
MMP11 3.74 6.8E−127 2.96E−03 0.44 0.44 (0.25–0.77) 3.68E−02 0.731 0.73 (0.54–0.98)
GRP 3.22 2.4E−15 1.43E−02 0.515 0.52 (0.3–0.88) 1.16E−04 0.554 0.55 (0.41–0.75)
TWIST1 2.59 1.3E−28 4.07E−02 0.562 0.56 (0.32–0.98) 4.29E−02 0.736 0.74 (0.55–0.99)
RGS16 2.29 2.1E−25 1.90E−04 0.346 0.35 (0.19–0.62) 3.48E−02 0.726 0.73 (0.54–0.98)
COL8A1 2.01 9.6E−15 1.68E−04 0.338 0.34 (0.19–0.61) 6.21E−03 0.661 0.66 (0.49–0.89)
TMEM37 0.47 1.3E−23 1.41E−02 1.986 1.99 (1.14–3.47) 1.28E−02 1.457 1.46 (1.08–1.96)
ARHGAP44 0.45 4.8E−20 4.88E−02 1.717 1.72 (1–2.96) 4.58E−02 1.349 1.35 (1–1.82)
  1. FC fold change, HR hazard ratio, CI confidence interval
  2. P < 0.05 was considered as significant different